View Item 

Show simple item record

Trends in the prevalence and mortality of cognitive impairment in the United States: Is there evidence of a compression of cognitive morbidity?
dc.contributor.authorLanga, Kenneth M.
dc.contributor.authorLarson, Eric B.
dc.contributor.authorKarlawish, Jason H.
dc.contributor.authorCutler, David M.
dc.contributor.authorKabeto, Mohammed U.
dc.contributor.authorKim, Scott Y.
dc.contributor.authorRosen, Allison B.
dc.date.accessioned2020-01-13T15:10:15Z
dc.date.available2020-01-13T15:10:15Z
dc.date.issued2008-03
dc.identifier.citationLanga, Kenneth M.; Larson, Eric B.; Karlawish, Jason H.; Cutler, David M.; Kabeto, Mohammed U.; Kim, Scott Y.; Rosen, Allison B. (2008). "Trends in the prevalence and mortality of cognitive impairment in the United States: Is there evidence of a compression of cognitive morbidity?." Alzheimer’s & Dementia 4(2): 134-144.
dc.identifier.issn1552-5260
dc.identifier.issn1552-5279
dc.identifier.urihttps://hdl.handle.net/2027.42/152800
dc.publisherAmerican Psychiatric Association
dc.publisherWiley Periodicals, Inc.
dc.subject.otherDementia
dc.subject.otherCardiovascular disease
dc.subject.otherEducation
dc.subject.otherEpidemiology
dc.titleTrends in the prevalence and mortality of cognitive impairment in the United States: Is there evidence of a compression of cognitive morbidity?
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelNeurology and Neurosciences
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/152800/1/alzjjalz200801001.pdf
dc.identifier.doi10.1016/j.jalz.2008.01.001
dc.identifier.sourceAlzheimer’s & Dementia
dc.identifier.citedreferenceK Langa, B Plassman, R Wallace, A Herzog, S Heeringa, MB Ofstedal, et al. The Aging, Demographics, and Memory Study: study design and methods. Neuroepidemiology. 25: 2005; 181 – 191
dc.identifier.citedreferenceN Scarmeas, SM Albert, JJ Manly, Y Stern. Education and rates of cognitive decline in incident Alzheimer’s disease. J Neurol Neurosurg Psychiatry. 77: 2006; 308 – 316
dc.identifier.citedreferenceY Stern, MX Tang, J Denaro, R Mayeux. Increased risk of mortality in Alzheimer’s disease patients with more advanced educational and occupational attainment. Ann Neurol. 37: 1995; 590 – 595
dc.identifier.citedreferenceJS Hui, RS Wilson, DA Bennett, JL Bienias, DW Gilley, DA Evans. Rate of cognitive decline and mortality in Alzheimer’s disease. Neurology. 61: 2003; 1356 – 1361
dc.identifier.citedreferenceFederal Interagency Forum on Aging-Related Statistics. Median household net worth of head of household http://www.agingstats.gov/chartbook2004/tables-economics.html#Indicator%2010, Accessed: November 4, 2006
dc.identifier.citedreferenceJS House, PM Lantz, P Herd. Continuity and change in the social stratification of aging and health over the life course: evidence from a nationally representative longitudinal study from 1986 to 2001/2002 (Americans’ Changing Lives Study). J Gerontol B Psychol Sci Soc Sci. 60 (Spec No 2): 2005; 15 – 26
dc.identifier.citedreferenceRF Schoeni, VA Freedman, LG Martin. Socioeconomic and demographic disparities in trends in old-age disability. 2005; Trends Working Paper Series: Ann Arbor, MI, number 05-1
dc.identifier.citedreferenceFT Juster, R Suzman. An overview of the health and retirement study. Journal of Human Resources. 30 (Suppl): 1995; S7 – S56
dc.identifier.citedreferenceHealth and retirement study. http://hrsonline.isr.umich.edu, Accessed: December 12, 2007
dc.identifier.citedreferenceL Kish. Survey sampling. New York: Wiley; 1965.
dc.identifier.citedreferenceA Herzog, R Wallace. Measures of cognitive functioning in the AHEAD study. J Gerontol Series B. 52B (Special Issue): 1997; 37 – 48
dc.identifier.citedreferenceKA Welsh, JCS Breitner, KM Magruder-Habib. Detection of dementia in the elderly using telephone screening of cognitive status. Neuropsychiatry Neuropsychol Behav Neurol. 6: 1993; 103 – 110
dc.identifier.citedreferenceK Langa, M Chernew, M Kabeto, A Herzog, MB Ofstedal, R Willis, et al. National estimates of the quantity and cost of informal caregiving for the elderly with dementia. J Gen Intern Med. 16: 2001; 770 – 778
dc.identifier.citedreferenceMB Ofstedal, GG Fisher, AR Herzog. Documentation of cognitive functioning measures in the Health and Retirement Study http://hrsonline.isr.umich.edu/docs/userg/dr-006.pdf, Accessed November 11, 2006
dc.identifier.citedreferenceDN Gujarati. Basic econometrics. New York: McGraw-Hill; 1988.
dc.identifier.citedreferenceVA Freedman, H Aykan, LG Martin. Another look at aggregate changes in severe cognitive impairment: further investigation into the cumulative effects of three survey design issues. J Gerontol B Psychol Sci Soc Sci. 57: 2002; S126 – S131
dc.identifier.citedreferenceA Jorm, B Rodgers, A Henderson, A Korten, P Jacomb, H Christensen, et al. Occupation type as a predictor of cognitive decline and dementia in old age. Age Ageing. 27: 1998; 477 – 483
dc.identifier.citedreferenceGG Potter, BL Plassman, MJ Helms, SM Foster, NW Edwards. Occupational characteristics and cognitive performance among elderly male twins. Neurology. 67: 2006; 1377 – 1382
dc.identifier.citedreferenceJ Verghese, R Lipton, M Katz, C Hall, C Derby, G Kuslansky, et al. Leisure activities and the risk of dementia in the elderly. N Engl J Med. 348: 2003; 2508 – 2516
dc.identifier.citedreferenceAB Rosen, DM Cutler, DM Norton, HM Hu, S Vijan. The value of coronary heart disease care in the elderly, 1987-2002 Health Affairs. 26: 2007; 111 – 123
dc.identifier.citedreferenceF Forette, M Seux, J Staessen, L Thijs, M Barbarskiene, S Babeanu, et al. The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study. Arch Intern Med. 162: 2002; 2046 – 2052
dc.identifier.citedreferenceA Khachaturian, P Zandi, C Lyketsos, K Hayden, I Skoog, MC Norton, et al. Antihypertensive medication use and incident Alzheimer disease: the Cache County Study. Arch Neurol. 63: 2006; 686 – 692
dc.identifier.citedreferenceSH Belle, S Zhang, SJ Czaja, R Burns, R Schulz. Use of cognitive enhancement medication in persons with Alzheimer disease who have a family caregiver: results from the Resources for Enhancing Alzheimer’s Caregiver Health (REACH) project. Am J Geriatr Psychiatry. 12: 2004; 250 – 257
dc.identifier.citedreferenceNE Morden, J Zerzan, EB Larson. Alzheimer’s disease medication use and cost projections for Medicare Part D. J Am Geriatr Soc. 55: 2007; 622 – 624
dc.identifier.citedreferenceWL Rodgers, MB Ofstedal, AR Herzog. Trends in scores on tests of cognitive ability in the elderly U.S. population, 1993-2000. J Gerontol B Psychol Sci Soc Sci. 58: 2003; S338 – S346
dc.identifier.citedreferenceJ Banaszak-Holl, AM Fendrick, N Foster, AR Herzog, M Kabeto, D Kent, et al. Predicting nursing home admission: estimates from a 7-year follow-up of a nationally representative sample of older Americans. Alzheimer Dis Assoc Disord. 18: 2004; 83 – 89
dc.identifier.citedreferenceAmerican Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. 1994; American Psychiatric Association: Washington, DC
dc.identifier.citedreferenceDM Cutler, M McClellan. Is technological change in medicine worth it?. Health Aff (Millwood). 20: 2001; 11 – 29
dc.identifier.citedreferenceKC Manton, XL Gu, SV Ukraintseva. Declining prevalence of dementia in the U.S. elderly population. Adv Gerontol. 16: 2005; 30 – 37
dc.identifier.citedreferenceNational Center for Health Statistics. Health, United States, 2005 http://www.cdc.gov/nchs/data/hus/hus05.pdf#summary, Accessed November 4, 2006
dc.identifier.citedreferenceK Yaffe, T Blackwell, AM Kanaya, N Davidowitz, E Barrett-Connor, K Krueger. Diabetes, impaired fasting glucose, and development of cognitive impairment in older women. Neurology. 63: 2004; 658 – 663
dc.identifier.citedreferenceM Kumari, M Marmot. Diabetes and cognitive function in a middle-aged cohort: findings from the Whitehall II study. Neurology. 65: 2005; 1597 – 1603
dc.identifier.citedreferenceSL Rogers, MR Farlow, RS Doody, R Mohs, LT Friedhoff. A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer’s disease: Donepezil Study Group. Neurology. 50: 1998; 136 – 145
dc.identifier.citedreferenceV Kumar, R Anand, J Messina, R Hartman, J Veach. An efficacy and safety analysis of Exelon in Alzheimer’s disease patients with concurrent vascular risk factors. Eur J Neurol. 7: 2000; 159 – 169
dc.identifier.citedreferenceT Erkinjuntti, A Kurz, S Gauthier, R Bullock, S Lilienfeld, CV Damaraju. Efficacy of galantamine in probable vascular dementia and Alzheimer’s disease combined with cerebrovascular disease: a randomised trial. Lancet. 359: 2002; 1283 – 1290
dc.identifier.citedreferenceD Wilkinson, R Doody, R Helme, K Taubman, J Mintzer, A Kertesz, et al. Donepezil in vascular dementia: a randomized, placebo-controlled study. Neurology. 61: 2003; 479 – 486
dc.identifier.citedreferenceR Doody, J Stevens, C Beck, R Dubinsky, J Kaye, L Gwyther, et al. Pratice parameter: management of dementia (an evidence-based review). Neurology. 56: 2001; 1154 – 1166
dc.identifier.citedreferenceD Geldmacher, G Provenzano, T McRae, V Mastey, J Ieni. Donepezil is associated with delayed nursing home placement in patients with Alzheimer’s disease. J Am Geriatr Soc. 51: 2003; 937 – 944
dc.identifier.citedreferenceC Courtney, D Farrell, R Gray, R Hills, L Lynch, E Sellwood, et al. Long-term donepezil treatment in 565 patients with Alzheimer’s disease (AD2000): randomised double-blind trial. Lancet. 363: 2004; 2105 – 2115
dc.identifier.citedreferenceLS Schneider. AD2000: donepezil in Alzheimer’s disease. Lancet. 363: 2004; 2100 – 2101
dc.identifier.citedreferenceKM Langa, NL Foster, EB Larson. Mixed dementia: emerging concepts and therapeutic implications. JAMA. 292: 2004; 2901 – 2908
dc.identifier.citedreferenceS Gillette-Guyonnet, S Andrieu, F Cortes, F Nourhashemi, C Cantet, PJ Ousset, et al. Outcome of Alzheimer’s disease: potential impact of cholinesterase inhibitors. J Gerontol A Biol Sci Med Sci. 61: 2006; 516 – 520
dc.identifier.citedreferenceFederal Interagency Forum on Aging-Related Statistics. Educational attainment of the population age 65 and over http://www.agingstats.gov/chartbook2004/tables-population.html#Indicator%204, Accessed November 4, 2006
dc.identifier.citedreferenceY Stern, B Gurland, TK Tatemichi, MX Tang, D Wilder, R Mayeux. Influence of education and occupation on the incidence of Alzheimer’s disease. JAMA. 271: 1994; 1004 – 1010
dc.identifier.citedreferenceL Hebert, P Scherr, J Bienias, D Bennett, D Evans. Alzheimer disease in the US population. Arch Neurol. 60: 2003; 1119 – 1122
dc.identifier.citedreferenceM Gatz, CA Prescott, NL Pedersen. Lifestyle risk and delaying factors. Alzheimer Dis Assoc Disord. 20: 2006; S84 – S88
dc.identifier.citedreferenceY Stern. Cognitive reserve and Alzheimer disease. Alzheimer Dis Assoc Disord. 20: 2006; S69 – S74
dc.identifier.citedreferenceC Qiu, L Backman, B Winblad, H Aguero-Torres, L Fratiglioni. The influence of education on clinically diagnosed dementia incidence and mortality data from the Kungsholmen Project. Arch Neurol. 58: 2001; 2034 – 2039
dc.identifier.citedreferenceV Freedman, H Aykan, L Martin. Aggregate changes in severe cognitive impairment among older Americans: 1993 and 1998. Journal of Gerontology: Social Sciences. 56B: 2001; S100 – S111
dc.identifier.citedreferenceKA Cagney, DS Lauderdale. Education, wealth, and cognitive function in later life. J Gerontol B Psychol Sci Soc Sci. 57: 2002; P163 – P172
dc.identifier.citedreferenceL Teri, SM McCurry, SD Edland, WA Kukull, EB Larson. Cognitive decline in Alzheimer’s disease: a longitudinal investigation of risk factors for accelerated decline. J Gerontol A Biol Sci Med Sci. 50A: 1995; M49 – M55
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
alzjjalz200801001.pdf
Size:
134.4KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.